Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Neuro-Oncology
|
July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Jian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation
Zachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
Cancer Research
|
August 10, 2017
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity
Frank Cichocki, Bahram Valamehr, Ryan Bjordahl, et al.
Science Translational Medicine
|
July 19, 2023
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma
Frank Cichocki, Bin Zhang, Cheng-Ying Wu, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Science Translational Medicine
|
November 5, 2020
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, et al.
Nature Communications
|
November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Blood
|
August 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency
Jacob Myers, Rih-Sheng Huang, Shee Kwan Phung, et al.
Science Immunology
|
March 13, 2021
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation
Tim D Holmes, Ram Vinay Pandey, Eric Y Helm, et al.
Nature Immunology
|
July 2, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneity
Lucas Rebuffet, Janine E Melsen, Bertrand Escalière, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Neuro-Oncology
|
July 11, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager
Jian-Fang Ning, Zachary B Davis, Qudsia Zeb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation
Zachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
Cancer Research
|
August 10, 2017
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity
Frank Cichocki, Bahram Valamehr, Ryan Bjordahl, et al.
Science Translational Medicine
|
July 19, 2023
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma
Frank Cichocki, Bin Zhang, Cheng-Ying Wu, et al.
Cancer Research Communications
|
January 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
John R Lozada, Andrew Elliott, Mark G Evans, et al.
Science Translational Medicine
|
November 5, 2020
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, et al.
Nature Communications
|
November 29, 2022
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, et al.
Blood
|
August 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency
Jacob Myers, Rih-Sheng Huang, Shee Kwan Phung, et al.
Science Immunology
|
March 13, 2021
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation
Tim D Holmes, Ram Vinay Pandey, Eric Y Helm, et al.
Nature Immunology
|
July 2, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneity
Lucas Rebuffet, Janine E Melsen, Bertrand Escalière, et al.
Page
of 7